A detailed history of Kathmere Capital Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 3,476 shares of BSX stock, worth $293,861. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,476
Previous 2,614 32.98%
Holding current value
$293,861
Previous $201,000 44.78%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$72.96 - $84.0 $62,891 - $72,408
862 Added 32.98%
3,476 $291,000
Q2 2024

Jul 17, 2024

BUY
$67.33 - $77.71 $176,000 - $203,133
2,614 New
2,614 $201,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Kathmere Capital Management, LLC Portfolio

Follow Kathmere Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.